On Jun. 22, 2020, Intravacc announced promising results of a preclinical study with its experimental whooping cough vaccine in mice. Published in Scientific Reports (2020) 10:7396, the study showed that intranasal immunization induced both excellent systemic and local immune responses, but also prevented colonization of the lung, trachea and nose.